Gainers
- TransCode Therapeutics (NASDAQ:RNAZ) stock rose 20.0% to $0.65 during Thursday's regular session. The market value of their outstanding shares is at $11.2 million.
- Vaccinex (NASDAQ:VCNX) shares increased by 18.88% to $2.14. The company's market cap stands at $5.5 million.
- NexGel (NASDAQ:NXGL) stock increased by 17.65% to $2.82. The market value of their outstanding shares is at $17.8 million.
- Cue Biopharma (NASDAQ:CUE) stock rose 17.01% to $1.41. The company's market cap stands at $84.8 million.
- Genenta Science (NASDAQ:GNTA) shares increased by 15.81% to $6.5. The company's market cap stands at $118.4 million.
- Regencell Bioscience (NASDAQ:RGC) shares moved upwards by 13.69% to $5.98. The company's market cap stands at $77.8 million.
Losers
- Gritstone Bio (NASDAQ:GRTS) stock declined by 64.2% to $0.07 during Thursday's regular session. The market value of their outstanding shares is at $8.3 million.
- 10x Genomics (NASDAQ:TXG) stock fell 25.21% to $15.57. The company's market cap stands at $1.8 billion.
- Healthcare Triangle (NASDAQ:HCTI) shares fell 21.17% to $0.4. The market value of their outstanding shares is at $2.2 million.
- ADMA Biologics (NASDAQ:ADMA) stock declined by 19.46% to $16.37. The market value of their outstanding shares is at $3.8 billion.
- Tempest Therapeutics (NASDAQ:TPST) shares decreased by 17.78% to $1.11. The company's market cap stands at $27.9 million.
- Indivior (NASDAQ:INDV) stock fell 17.27% to $7.81. The company's market cap stands at $1.0 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CUECue Biopharma Inc
$0.31002.65%
GNTAGenenta Science SPA
$1.30-%
HCTIHealthcare Triangle Inc
$0.4483-1.04%
INDVIndivior PLC
$32.580.12%
NXGLNexGel Inc
$1.631.24%
RGCRegencell Bioscience Holdings Ltd
$27.25-0.66%
RNAZTransCode Therapeutics Inc
$8.00-10.5%
TPSTTempest Therapeutics Inc
$2.740.74%
TXG10x Genomics Inc
$20.40-0.58%
VCNXVaccinex Inc
$0.9480-4.26%
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
